These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7555960)

  • 1. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia.
    Jensen FE; Blume H; Alvarado S; Firkusny I; Geary C
    Epilepsia; 1995 Oct; 36(10):966-72. PubMed ID: 7555960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury.
    Koh S; Tibayan FD; Simpson JN; Jensen FE
    Epilepsia; 2004 Jun; 45(6):569-75. PubMed ID: 15144420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epileptogenic effect of seizures induced by hypoxia: the role of NMDA and AMPA/KA antagonists.
    Rubaj A; Zgodziński W; Sieklucka-Dziuba M
    Pharmacol Biochem Behav; 2003 Jan; 74(2):303-11. PubMed ID: 12479949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced hyperexcitability in vivo and in vitro in the immature hippocampus.
    Jensen FE; Wang C
    Epilepsy Res; 1996 Dec; 26(1):131-40. PubMed ID: 8985695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of excitatory amino acid antagonists NBQX and MK-801 on the developing brain.
    Tandon P; Liu Z; Stafstrom CE; Sarkisian M; Werner SJ; Mikati M; Yang Y; Holmes GL
    Brain Res Dev Brain Res; 1996 Sep; 95(2):256-62. PubMed ID: 8874901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate blocks perinatal hypoxia-induced seizures in rat pups.
    Koh S; Jensen FE
    Ann Neurol; 2001 Sep; 50(3):366-72. PubMed ID: 11558793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures.
    Sanchez RM; Koh S; Rio C; Wang C; Lamperti ED; Sharma D; Corfas G; Jensen FE
    J Neurosci; 2001 Oct; 21(20):8154-63. PubMed ID: 11588188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ; Gasparini F; Markou A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest.
    Brambrink AM; Martin LJ; Hanley DF; Becker KJ; Koehler RC; Traystman RJ
    J Cereb Blood Flow Metab; 1999 Aug; 19(8):927-38. PubMed ID: 10458600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
    DeGiorgio LA; DeGiorgio N; Volpe BT
    Neuroscience; 1999 Apr; 90(1):79-85. PubMed ID: 10188935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
    Kapus G; Székely JI; Durand J; Ruiz A; Tarnawa I
    Brain Res Bull; 2000 Aug; 52(6):511-7. PubMed ID: 10974490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of prolactin secretion by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in male rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 2000 Sep; 166(3):669-75. PubMed ID: 10974660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid: the protective effect of NMDA and non-NMDA receptor antagonists.
    Folbergrová J; Haugvicová R; Mares P
    Exp Neurol; 2000 Jan; 161(1):336-45. PubMed ID: 10683299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
    Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
    J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
    Lockhart B; Iop F; Closier M; Lestage P
    Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An animal model of hypoxia-induced perinatal seizures.
    Jensen FE
    Ital J Neurol Sci; 1995; 16(1-2):59-68. PubMed ID: 7642353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.
    Folbergrová J
    Exp Neurol; 1994 Dec; 130(2):344-50. PubMed ID: 7867764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
    Abraham KE; McGinty JF; Brewer KL
    Neuroscience; 2001; 104(3):863-74. PubMed ID: 11440816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.